Data gathered: October 7
Alternative Data for Structure Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 12 | Sign up | Sign up | Sign up |
| Sentiment | 92 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 19 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,386 | Sign up | Sign up | Sign up |
| Twitter Followers | 332 | Sign up | Sign up | Sign up |
| X Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 171 | Sign up | Sign up | Sign up |
About Structure Therapeutics
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.
| Price | $28.42 |
| Target Price | Sign up |
| Volume | 702,730 |
| Market Cap | $1.57B |
| Year Range | $14.15 - $30.75 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Structure Therapeutics Inc. Sponsored ADR $GPCR Stake Boosted by Signaturefd LLCOctober 4 - ETF Daily News |
 |
Structure Therapeutics: The Dark Horse In The Oral Obesity GLP-1 ArenaOctober 2 - SeekingAlpha |
|
Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head SurveyOctober 2 - ETF Daily News |
 |
Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity DataSeptember 21 - Yahoo Entertainment |
|
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives $75.71 Consensus PT from AnalystsSeptember 21 - ETF Daily News |
|
Research Analysts Issue Forecasts for GPCR Q3 EarningsSeptember 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 0 | 850,000 | -850,000 | -62M | -61M | -0.360 |
| Q1 '25 | 0 | 0 | 0 | -47M | -56M | -0.270 |
| Q4 '24 | 0 | 0 | 0 | -36M | -47M | -0.210 |
| Q3 '24 | 0 | 0 | 0 | -34M | -46M | -0.200 |
| Q2 '24 | 0 | 230,000 | -230,000 | -26M | -33M | -0.180 |
Insider Transactions View All
| FMR LLC filed to sell 1,515,558 shares at $17.9. August 1 '25 |
| FMR LLC filed to sell 1,541,868 shares at $35. March 18 '24 |
Similar companies
Read more about Structure Therapeutics (GPCR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, x mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Structure Therapeutics?
The Market Cap of Structure Therapeutics is $1.57B.
What is the current stock price of Structure Therapeutics?
Currently, the price of one share of Structure Therapeutics stock is $28.42.
How can I analyze the GPCR stock price chart for investment decisions?
The GPCR stock price chart above provides a comprehensive visual representation of Structure Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Structure Therapeutics shares. Our platform offers an up-to-date GPCR stock price chart, along with technical data analysis and alternative data insights.
Does GPCR offer dividends to its shareholders?
As of our latest update, Structure Therapeutics (GPCR) does not offer dividends to its shareholders. Investors interested in Structure Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Structure Therapeutics?
Some of the similar stocks of Structure Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
